NDC 51655-252 – Hydroxyzine Pamoate
Hydroxyzine Pamoate 50 mg/1 · Capsule · Oral
Product NDC51655-252
Product details
- Brand name
- Hydroxyzine Pamoate
- Generic name
- Hydroxyzine Pamoate
- Labeler
- Northwind Health Company, LLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA088487
- Marketed since
- April 25, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Antihistamine
Active ingredients
- Hydroxyzine Pamoate 50 mg/1
Uses, dosage, side effects and warnings for Hydroxyzine Pamoate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 51655-252-52 | 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-252-52) | Apr 25, 2023 |
Other Hydroxyzine Pamoate products
- 50090-7540 Hydroxyzine Pamoate 50 mg/1 · Capsule · A-S Medication Solutions
- 50090-5933 Hydroxyzine Pamoate 50 mg/1 · Capsule · A-S Medication Solutions
- 50090-4579 Hydroxyzine Pamoate 25 mg/1 · Capsule · A-S Medication Solutions
- 50090-4385 Hydroxyzine Pamoate 25 mg/1 · Capsule · A-S Medication Solutions
- 60687-696 Hydroxyzine Pamoate 25 mg/1 · Capsule · American Health Packaging
- 60687-707 Hydroxyzine Pamoate 50 mg/1 · Capsule · American Health Packaging
- 0115-1803 Hydroxyzine Pamoate 25 mg/1 · Capsule · Amneal Pharmaceuticals of New York LLC
- 0115-1804 Hydroxyzine Pamoate 50 mg/1 · Capsule · Amneal Pharmaceuticals of New York LLC
- 71610-883 Hydroxyzine Pamoate 25 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 71610-773 Hydroxyzine Pamoate 25 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 71610-747 Hydroxyzine Pamoate 25 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 71610-217 Hydroxyzine Pamoate 25 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC